share_log

Transcode Therapeutics | EFFECT: Others

SEC announcement ·  Jan 19 00:00
Summary by Moomoo AI
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by Transcode Therapeutics, Inc. effective as of January 18, 2024, at 1:00 P.M. The Form S-1 is a registration statement that companies use to register their securities before they can be offered to the public. The effectiveness of this form indicates that Transcode Therapeutics has met all the necessary regulatory requirements to proceed with its public offering.
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by Transcode Therapeutics, Inc. effective as of January 18, 2024, at 1:00 P.M. The Form S-1 is a registration statement that companies use to register their securities before they can be offered to the public. The effectiveness of this form indicates that Transcode Therapeutics has met all the necessary regulatory requirements to proceed with its public offering.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more